Spectrum of Fuchs Uveitic Syndrome in a North Indian Population

REFERENCES

• Kazokoglu H, Onal S, Tugal-Tutkun I, et al. Demographic and clinical features of uveitis in tertiary centers in Turkey. Ophthalmic Epidemiol. 2008; 15: 285–293.
   PubMed Web of Science ®Google Scholar
• Rathinam SR, Namperumalsamy P. Global variation and pattern changes in epidemiology of uveitis. Indian J Ophthalmol. 2007;55: 173–183.
   PubMedGoogle Scholar
• Wakefield D, Chang JH. Epidemiology of uveitis. Int Ophthalmol Clin.2005; 45: 1–13.
   PubMedGoogle Scholar
• Rodriguez A, Calonge M, Pedroza-Seres M, et al. Referral patterns of uveitis in a tertiaryeye care center. Arch Ophthalmol.1996; 114: 593–599.
   PubMed Web of Science ®Google Scholar
• Gritz DC, Wong IG. Incidence and prevalence of uveitis in Northern California, the Northerm California Epidemiology of Uveitis Study. Ophthalmology.2004; 111: 491–500.
   PubMed Web of Science ®Google Scholar
• Tran VT, Auer C, Guex-Crosier Y, Pittet N, Herbort CP. Epidemiological characteristics of uveitis in Switzerland. Int Ophthalmol. 1994–1995; 18: 293–298.
   Web of Science ®Google Scholar
• Das D, Bhattacharjee H, Bhattacharya PK. Patterns of uveitis in North East India: a tertiary care center study. Indian J Ophthalmol.2009;57:144–146.
   PubMed Web of Science ®Google Scholar
• Singh R, Gupta V, Gupta A. Pattern of uveitis in a referral eye clinic in North India. Indian J Ophthalmol. 2004; 52:121–125.
   PubMedGoogle Scholar
• Mohamed Q, Zamir E. Update on Fuchs’ uveitis syndrome. Curr Opin Ophthalmol. 2005;16:356–363.
   PubMedGoogle Scholar
• Jones NP. Fuchs’heterochromic uveitis: an update. Surv Ophthalmol.1993; 37:253–272.
   PubMed Web of Science ®Google Scholar
• Tugal-Tutkun I, Guney-Tefekli E, Kamaci-Duman F, Corum I. A cross-sectional and longitudinal study of Fuchs uveitis syndrome in Turkish population. Am J Ophthalmol. 2009;118(4):510–515.
   Google Scholar
• Yang P, Fang W, Jin H, Li B, Chen X, Kijlstra A. Clinicalfeatures of Chinese patients with Fuchs’ syndrome. Ophthalmology.2006;113:473–480.
   PubMed Web of Science ®Google Scholar
• Arellanes-Garcia L, Preciado-Delgadillo MDC, Recillas-GispertC. Fuchs’heterochromiciridocyclitis: clinical manifestations in dark-eyed Mexican patients. Ocul Immunol Inflamm. 2002;10:125–131.
   PubMed Web of Science ®Google Scholar
• Tabbut BR, Tessler HH, Williams D. Fuchs’heterochromiciridocyclitis in blacks. Arch Ophthalmol. 1988;106:1688–1690.
   PubMedGoogle Scholar
• Rothova A, La Hey E, Baarsma GS, Breebaart AC. Iris nodules in Fuchs’heterochromic uveitis. Am J Ophthalmol. 1994;118:338–342.
   PubMed Web of Science ®Google Scholar
• Chee SP, Jap A. Presumed Fuchs heterochromiciridocyclitisand Posner-Schlossman syndrome: comparison of cytomegalovirus-positive and -negative eyes. Am J Ophthalmol.2008;146:883–889.
   PubMed Web of Science ®Google Scholar
• Chee SP, Bacsal K, Jap A, Se-Thoe SY, Cheng CL, Tan BH. Clinical features of cytomegalovirus anterior uveitis in immunocompetentpatients. Am J Ophthalmol. 2008;145:834–840.
   PubMed Web of Science ®Google Scholar
• Birnbaum AD, Tessler HH, Schultz KL, et al. Epidemiologic relationship between Fuchs heterochromiciridocyclitis and the United States rubella vaccination program. Am J Ophthalmol. 2007;144:424–428.
   PubMed Web of Science ®Google Scholar
• Quentin CD, Reiber H. Fuchs heterochromiccyclitis: rubella virus antibodies and genome in aqueous humor. Am J Ophthalmol. 2004;138:46–54.
   PubMed Web of Science ®Google Scholar
• De Groot-Mijnes JDF, de Visser L, Rothova A, Schuller M, van Loon AM, Weersink AJL. Rubella virus is associated with Fuchs heterochromiciridocyclitis. Am J Ophthalmol. 2006;141:212–214.
   PubMed Web of Science ®Google Scholar
• De Visser L, Braakenburg A, Rothova A, de Boer JH. Rubella virus-associated uveitis: clinical manifestations and visual prognosis. Am J Ophthalmol. 2008;146:292–297.
   PubMed Web of Science ®Google Scholar
• Beneyto P, Fernandez MJ, Gracia A, Ibanez M, Garcia-Aparicio A, Morente P. Fuchs’heterochromiccyclitiswithout heterochromia: a diagnostic approach. Arch Sco Esp Oftalmol.2007; 82:355–359.
   PubMedGoogle Scholar
• Mohamed Q, Zamir E. Update on Fuchs’ uveitis syndrome. Curr Opin Ophthalmol.2005; 16:356–363.
   PubMedGoogle Scholar
• Bouchenaki N,Herbort CP. Fuchs’uveitis: failure to associate vitritis and disc hyperfluorescence with the disease is the major factor for misdiagnosis and diagnostic delay. Middle East Afr J Ophthalmol. 2009; Oct-Dec; 16(4): 239–244.
   PubMedGoogle Scholar
• Jones NP. Fuchs’heterochromic uveitis: a reappraisal of the clinical spectrum. Eye. 1991;5:649–661.
   PubMedGoogle Scholar
• Fearnley IR, Rosenthal AR. Fuchs’heterochromiciridocyclitis revisited. Acta Ophthalmol Scand. 1995; 73:166–170.
   PubMedGoogle Scholar
• Velilla S, Dios E, Herreras JM, Calonge M. Fuchs’heterochromiciridocyclitis: areview of 26 cases. Ocul Immunol Inflamm. 2001; 9:169–175.
   PubMed Web of Science ®Google Scholar
• Fuchs E. Aetiologie und Formen der Iridozyklitis. In: Fuchs E, ed. Lehrbuch der Augenheilkunde. Franz Deuticke: Leipzig und Wien; 1926;463–471.
   Google Scholar
• Norrsell K, Sjödell L. Fuchs’heterochromic uveitis: a longitudinalclinical study. Acta Ophthalmol. 2008;86:58–64.
   PubMed Web of Science ®Google Scholar
• Liesegang TJ. Clinical features and prognosis in Fuchs’uveitis syndrome. Arch Ophthalmol. 1982;100:1622–1626.
   PubMed Web of Science ®Google Scholar
• La Hey E, Baarsma GS, De Vries J, Kijlstra A. Clinicalanalysis of Fuchs’heterochromiccyclitis. Doc Ophthalmol.1991;78:225–235.
   PubMed Web of Science ®Google Scholar
• Bouchenaki N, Herbort CP. Fluorescein angiographic findings and clinical features in Fuchs’ uveitis. Int Ophthalmol. 2010; 30(5):511–519.
   PubMedGoogle Scholar
• Liesegang TJ. Clinical features and prognosis in Fuchs’ uveitis syndrome. Arch Ophthalmol. 1982;100:1622–1626.
   PubMed Web of Science ®Google Scholar